Benefit of Cusp overlap method for self‐expanding transcatheter aortic valves

The need for permanent pacemaker implantation (PPM) continues to be one of the main challenges in TAVR, especially with self-expanding valves, with a pacemaker implantation rate that varies between 17.5% and 30% in large randomized studies, vs. 4% to 6.5% with self-expanding valves.

Beneficio del implante alto de las válvulas aórticas percutáneas autoexpandibles 

Therefore, in an attempt to prevent the need for PPM implantation, the cusp overlapping technique has been developed (COT) which several analysts have shown has a lower rate vs the conventional implantation technique also called three cusp technique (3C). However, at present, this technique still calls for robust, large randomized trials. 

This study looked at 647 patients undergoing TAVR with self-expanding EVOLUT; 519 (80.2%) with the COT technique.

Both groups were similar, with mean age 82, but surgical scores were higher in those treated with the 3C technique. 

Left ventricular function was higher in COT patients (58% vs. 53%, p<0.001), with 41 mmHg gradient and close to 2% bicuspid valves. 

Read also: Does Post-Dilation in TAVR Affect its Long-Term Outcomes?

Valve 29 was the most used (45%), followed by the 26 (35%), and 34 (12%) and, in lower numbers, the 23; the transfemoral approach was used in nearly all patients.

At 30 days, patients treated with the COT technique showed lower need for PPM implantation (10% vs. 21%, p=<0.001) and one new AV block (11% vs. 23%, p<0.001), with no difference in new intraventricular conduction block. 

Conclusion

COT presents some potential technical advantages vs. 3C, and perhaps a lower rate of PPM implantation in TAVR with self-expanding EVOLUT. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Cusp overlap method for self‐expanding transcatheter aortic valve replacement.

Reference: Talal F. Aljabbary, et al. Catheter Cardiovasc Interv. 2024;103:202–208.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...